GeneDx Holdings Corp.

NasdaqGS:WGS Stock Report

Market Cap: US$3.4b

GeneDx Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:WGS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Sep 25SellUS$452,850Kevin FeeleyIndividual3,728US$121.47
27 Aug 25SellUS$4,995,801Jason RyanIndividual39,222US$130.01
22 Aug 25SellUS$60,451,950Casdin Capital, LLCCompany500,000US$120.90
14 May 25BuyUS$3,007,997Corvex Management LPCompany50,000US$60.52
08 May 25BuyUS$5,600,994Corvex Management LPCompany100,000US$57.53
13 Mar 25SellUS$96,420Katherine StuelandIndividual1,078US$89.44
13 Mar 25SellUS$36,202Kevin FeeleyIndividual402US$90.05
20 Feb 25SellUS$31,711,370Mount Sinai School Of Medicine, Endowment ArmCompany306,447US$108.57
18 Feb 25SellUS$88,772,194Mount Sinai School Of Medicine, Endowment ArmCompany1,039,676US$100.41
20 Nov 24SellUS$38,131,572OPKO Health, Inc.Company500,833US$80.16
20 Nov 24SellUS$3,316,880Jason RyanIndividual47,000US$72.26
18 Nov 24SellUS$10,393,723Mount Sinai School Of Medicine, Endowment ArmCompany147,141US$70.78
07 Nov 24SellUS$22,973,428OPKO Health, Inc.Company300,000US$77.22
31 Oct 24SellUS$64,935,000Mount Sinai School Of Medicine, Endowment ArmCompany865,800US$75.00

Insider Trading Volume

Insider Buying: WGS insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of WGS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies333,1440.954%
Individual Insiders447,5131.28%
Public Companies1,393,5523.99%
VC/PE Firms3,026,4118.67%
Hedge Funds3,058,6298.76%
Institutions26,660,48676.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 87.09% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.7%
Corvex Management LP
3,058,629US$359.0m0%12.09%
10.5%
Casdin Capital, LLC
3,026,411US$355.2m-13.7%28.26%
5.68%
William Blair Investment Management, LLC
1,631,402US$191.5m37.2%0.22%
4.99%
BlackRock, Inc.
1,434,634US$168.4m25%no data
4.78%
Icahn School of Medicine at Mount Sinai
1,373,569US$161.2m0%88.96%
4.77%
OPKO Health, Inc.
1,370,841US$160.9m0%no data
4.25%
Pentwater Capital Management LP
1,220,000US$143.2m3,710%3.45%
4.11%
The Vanguard Group, Inc.
1,180,923US$138.6m14.5%no data
3.66%
T. Rowe Price Group, Inc.
1,052,171US$123.5m104%0.01%
3.65%
UBS Asset Management AG
1,049,881US$123.2m1,210%0.01%
3.4%
The Goldman Sachs Group, Inc.
976,906US$114.7m-5.37%0.04%
3.21%
Oracle Investment Management, Inc.
922,454US$108.3m-4.9%75.87%
2.86%
Fred Alger Management, LLC
820,523US$96.3m47.3%0.36%
2.67%
Summit Partners Public Asset Management, LLC
767,265US$90.1m-36.2%3.06%
2.05%
Westfield Capital Management Company, L.P.
589,188US$69.2m165%0.27%
2.04%
Zweig-DiMenna Associates, Inc.
586,100US$68.8m28.2%5.92%
1.91%
Invesco Ltd.
549,229US$64.5m41.8%0.02%
1.69%
Geode Capital Management, LLC
484,714US$56.9m23.4%no data
1.63%
Morgan Stanley
467,619US$54.9m164%0.01%
1.51%
Lord, Abbett & Co. LLC
434,472US$51.0m6.14%0.15%
1.45%
State Street Global Advisors, Inc.
415,996US$48.8m22.5%no data
1.44%
Raymond James Financial, Inc.
413,223US$48.5m24%0.02%
1.42%
Wellington Management Group LLP
406,573US$47.7m-4.48%0.01%
1.39%
Jennison Associates LLC
397,896US$46.7m6,160%0.02%
1.35%
AllianceBernstein L.P.
386,758US$45.4m-11.5%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 17:34
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GeneDx Holdings Corp. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroBTIG
William BonelloCraig-Hallum Capital Group LLC
Keith HintonFreedom Capital Markets